Can a diabetes pill boost dialysis success? new study aims to find out.
NCT ID NCT07491042
First seen Mar 28, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This study tests whether dapagliflozin, a diabetes drug, can help people with end-stage kidney disease on peritoneal dialysis remove more fluid and improve dialysis quality. About 30 adults and teens will take the drug daily for six months. Researchers will measure changes in fluid removal, urine output, and dialysis adequacy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE CHRONIC RENAL FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jehad Badawi AL LAHAM
RECRUITINGNizwa, Oman
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.